Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Conti

Showing results (501-510 of 899) with videos related to

Pageof 90
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptorM Bellone, N Ostlie, S J Lei, et al.
Clinical Imaging|April 29, 1998
US and CT findings of secondary neoplasms of the thyroid--a pictorial essayF Ferrozzi, D Bova, F Campodonico, et al.
British Journal of Pharmacology|September 2, 2014
Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in ratsD Lindenbach, N Palumbo, C Y Ostock, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient miceS L Jin, F J Richard, W P Kuo, et al.
Scandinavian Journal of Immunology|August 1, 1995
Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous miceP I Karachunski, N Ostlie, M Bellone, et al.
The Journal of Biological Chemistry|December 10, 1976
Gonadotropin-induced loss of hormone receptors and desensitization of adenylate cyclase in the ovaryM Conti, J P Harwood, A J Hsueh, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1991
Activation of blood coagulation and fibrinolysis in Graves' diseaseF Marongiu, M Conti, M L Murtas, et al.
European Journal of Neurology|August 13, 2025
Efgartigimod as Add-On Treatment in Refractory Guillain-Barré Syndrome: A Case ReportP Ripellino, D Dinacci, M Conti, et al.
Oncology|January 1, 1989
5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancerM Lopez, P Papaldo, L Di Lauro, et al.
Journal of Viral Hepatitis|December 20, 2007
Underestimation of chronic hepatitis B virus infection in the United States of AmericaC Cohen, A A Evans, W T London, et al.
Pageof 90

Showing results (501-510 of 899) with videos related to

Sort By:
Pageof 90
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptorM Bellone, N Ostlie, S J Lei, et al.
Clinical Imaging|April 29, 1998
US and CT findings of secondary neoplasms of the thyroid--a pictorial essayF Ferrozzi, D Bova, F Campodonico, et al.
British Journal of Pharmacology|September 2, 2014
Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in ratsD Lindenbach, N Palumbo, C Y Ostock, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient miceS L Jin, F J Richard, W P Kuo, et al.
Scandinavian Journal of Immunology|August 1, 1995
Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous miceP I Karachunski, N Ostlie, M Bellone, et al.
The Journal of Biological Chemistry|December 10, 1976
Gonadotropin-induced loss of hormone receptors and desensitization of adenylate cyclase in the ovaryM Conti, J P Harwood, A J Hsueh, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1991
Activation of blood coagulation and fibrinolysis in Graves' diseaseF Marongiu, M Conti, M L Murtas, et al.
European Journal of Neurology|August 13, 2025
Efgartigimod as Add-On Treatment in Refractory Guillain-Barré Syndrome: A Case ReportP Ripellino, D Dinacci, M Conti, et al.
Oncology|January 1, 1989
5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancerM Lopez, P Papaldo, L Di Lauro, et al.
Journal of Viral Hepatitis|December 20, 2007
Underestimation of chronic hepatitis B virus infection in the United States of AmericaC Cohen, A A Evans, W T London, et al.
Pageof 90